Ana Guelar

2.8k total citations
48 papers, 2.0k citations indexed

About

Ana Guelar is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Ana Guelar has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 17 papers in Virology and 17 papers in Emergency Medicine. Recurrent topics in Ana Guelar's work include HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (17 papers) and HIV-related health complications and treatments (17 papers). Ana Guelar is often cited by papers focused on HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (17 papers) and HIV-related health complications and treatments (17 papers). Ana Guelar collaborates with scholars based in Spain, United States and United Kingdom. Ana Guelar's co-authors include Hernando Knobel, José L. López-Colomés, Alexia Carmona, Joan A. Caylà, Patricia García de Olalla, M. Montero, Pere Saballs, Adolfo Díez‐Pérez, Juan Pedro‐Botet and J. Gimeno and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Ana Guelar

46 papers receiving 2.0k citations

Peers

Countries citing papers authored by Ana Guelar

Since Specialization

Citations

This map shows the geographic impact of Ana Guelar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Guelar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Guelar more than expected).

Fields of papers citing papers by Ana Guelar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Guelar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Guelar. The network helps show where Ana Guelar may publish in the future.

Co-authorship network of co-authors of Ana Guelar

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Guelar. A scholar is included among the top collaborators of Ana Guelar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Guelar. Ana Guelar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and Validation of a Risk Score for Predicting Non-Adherence to Antiretroviral Therapy 2023 ·AIDS Research and Human Retroviruses ·(unknown), Sònia Luque, Isaac Subirana, Joan Vila, (unknown), Ana Guelar, (unknown), (unknown), Hernando Knobel	0
2	Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment 2021 ·Revista Española de Quimioterapia ·Maria Molas, Hernando Knobel, Olivia Ferrández, (unknown), (unknown), (unknown), Sònia Luque, Ana Guelar, (unknown), (unknown)	6
3	Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate 2018 ·AIDS ·Robert Güerri‐Fernández, (unknown), (unknown), Natalia García‐Giralt, Judit Villar-García, (unknown), (unknown), (unknown), Ana Guelar, Adolfo Díez‐Pérez, Todd T. Brown, Hernando Knobel	23
4	Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial 2017 ·PLoS ONE ·Judit Villar-García, Robert Güerri‐Fernández, Andrés Moyá, Alicia González, Juan Jesús Cruz, (unknown), Ana Guelar, Luisa Sorlí, Juan Pablo Horcajada, Alejandro Artacho, (unknown), Hernando Knobel	41
5	Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected MSM 2017 ·AIDS ·Joaquín Burgos, Adrián Curran, Stefania Landolfi, Ana Guelar, Lucía García San Miguel, (unknown), (unknown), Jordi Navarro, Javier Hernández‐Losa, Vicenç Falcó	16
6	The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona 2016 ·HIV Clinical Trials ·Sabina Herrera, Ana Guelar, Luisa Sorlí, Joan Vila, (unknown), María Grau, Jaume Marrugat, (unknown), Robert Güerri‐Fernández, M. Montero, Hernando Knobel	14
7	Risk of progression to high-grade anal intraepithelial neoplasia in HIV-infected MSM 2015 ·AIDS ·Joaquín Burgos, Adrián Curran, N Tallada, Ana Guelar, Jordi Navarro, Stefania Landolfi, (unknown), Manel Crespo, Esteban Ribera, Vicenç Falcó	32
8	Use of Non-Nucleoside Analogues Together with Rifampin in HIV Patients with Tuberculosis 2011 ·HIV Clinical Trials ·(unknown), (unknown), Alicia González, Luisa Sorlí, M. Montero, Ana Guelar, (unknown), (unknown), Hernando Knobel	3
9	Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009 2011 ·AIDS Research and Therapy ·(unknown), (unknown), M. A. Sambeat, I Ocaña, Hernando Knobel, (unknown), Peré Domingo, Esteban Ribera, Ana Guelar, Andrés Marco, María José Belza, Josep M. Miró, Joan A. Caylà, (unknown)	48
10	Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long‐term follow‐up 2009 ·HIV Medicine ·Hernando Knobel, (unknown), Alicia González, (unknown), M. Montero, (unknown), Ana Guelar	29
11	Risk of side effects associated with the use of nevirapine in treatment‐naïve patients, with respect to gender and CD4 cell count 2008 ·HIV Medicine ·Hernando Knobel, Ana Guelar, Marta Montero, (unknown), Sònia Luque, (unknown), Alicia González	28
12	Global Cardiovascular Risk in Patients with HIV Infection: Concordance and Differences in Estimates According to Three Risk Equations (Framingham, SCORE, and PROCAM) 2007 ·AIDS Patient Care and STDs ·Hernando Knobel, Carlos Rilova Jericó, M. Montero, M.L. Sorli, (unknown), Ana Guelar, Pere Saballs, Juan Pedro‐Botet	51
13	Hypertension in HIV-Infected Patients: Prevalence and Related Factors 2005 ·American Journal of Hypertension ·(unknown), Hernando Knobel, M. Montero, M.L. Sorli, Ana Guelar, J. Gimeno, Pere Saballs, (unknown), Juan Pedro‐Botet	79
14	Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain 2005 ·Journal of Medical Virology ·Carlos Toro, Rafael Benito, Antonio Aguilera, (unknown), Carmen Rodríguez, Enrique J. Calderón, Estrella Caballero, (unknown), Juan González‐García, Manuel Rodríguez‐Iglesias, Ana Guelar, Jorge del Romero, Vincent Soriano	15
15	Simplified Therapy with Zidovudine, Lamivudine, and Abacavir for Very Nonadherent, Treatment-Failing Patients 2004 ·HIV Clinical Trials ·Hernando Knobel, Gabriel Vallecillo, Ana Guelar, Enric Pedrol, Ana Soler, Alexia Carmona, Pere Saballs, Alicia González, J. Gimeno, (unknown)	6
16	Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients 2002 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Patricia García de Olalla, Hernando Knobel, Alexia Carmona, Ana Guelar, José L. López-Colomés, Joan A. Caylà	350
17	Virologic Outcome and Predictors of Virologic Failure of Highly Active Antiretroviral Therapy Containing Protease Inhibitors 2001 ·AIDS Patient Care and STDs ·Hernando Knobel, Ana Guelar, Alexia Carmona, (unknown), Alicia González, José L. López-Colomés, (unknown), J. Gimeno, Adolfo Díez‐Pérez	72
18	High Incidence of Herpes Zoster in Patients with AIDS Soon After Therapy with Protease Inhibitors 1998 ·Clinical Infectious Diseases ·Estebán Martínez, José M. Gatell, (unknown), E. Ubiña Aznar, (unknown), Ana Guelar, José Mallolas, E Soriano	103
19	Patterns of resistance of Mycobacterium tuberculosis in Spanish patients infected with human immunodeficiency virus type 1 (HIV-1) 1995 ·Clinical Microbiology and Infection ·Ana Guelar, Julian González-Martín, José M. Gatell, (unknown), José Mallolas, (unknown), José M. Miró, Laura Zamora, (unknown), E Soriano	2
20	A prospective study of the risk of tuberculosis among HIV-infected patients 1993 ·AIDS ·Ana Guelar, José M. Gatell, (unknown), (unknown), Luisa Seco Lozano, E. Ubiña Aznar, José M. Miró, José Mallolas, Laura Zamora, J. González, E Soriano	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact